Renu Dayal

Dr. Renu Dayal

Sanorva Biotech Pvt. Ltd.
+1

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Journal of Cancer Research and Therapeutics
Verified
Journal Article
Closed access
RDRenu Dayal
Renu Dayal
ASAmrita Singh
Amrita Singh
APAnubhuti Pandey
Anubhuti Pandey
KMKaushala Prasad Mishra
Kaushala Prasad Mishra
In normal functioning of the cell, there is a balance between generation and neutralization of reactive oxygen species (ROS) by endogenous cellular defense machinery. Low levels of ROS inside the cells are required for normal functioning of the cell, which regulate signaling mechanisms involved in mitosis and apoptosis; excess of ROS production may cause oxidative stress leading to damage in vital cellular molecules, namely cytosolic lipids, proteins, and DNA. In the situation of intracellular redox imbalance, molecules of cells are altered by ROS leading to pathogenic state. It is to be noted that ROS is not only known to be involved in tumor induction and progression processes but also enhances tumor cell radiosensitivity. The level of ROS-mediated oxidative stress is linked to cellular radiosensitivity. In general, cancer cells exhibit high levels of ROS, which forms a target for selectively killing them by radiation. In this paper, we have reviewed how oxidative stress determines the radiosensitivity of tumor cells involving ROS in the mechanism of radiation induced tumor cell killing. It is suggested that radiation-induced ROS play a key role in the mechanism of tumor cell killing by altering the signaling network and triggering of apoptosis. Furthermore, it is pointed out that combined use of plant-derived antioxidants and radiation enhance overproduction of ROS in tumor cells leading to enhanced radiosensitivity, which may find practical applications in clinic

8 January 2021 in Cells
Verified
Journal Article
Open access
PDF file
FTFlavia Tortolici
Flavia Tortolici
SVSimone Vumbaca
Simone Vumbaca
BIBernadette Incocciati
Bernadette Incocciati
RDRenu Dayal
Renu Dayal
KAKATIA AQUILANO
KATIA AQUILANO
SRStefano Rufini
Stefano Rufini
Radiation therapy is one of the most effective methods of tumor eradication; however, in some forms of neuroblastoma, radiation can increase the risk of secondary neoplasms, due to the ability of irradiated cells to transmit pro-survival signals to non-irradiated cells through vesicle secretion. The aims of this study were to characterize the vesicles released by the human neuroblastoma cell line SH-SY5Y following X-ray radiations and their ability to increase invasiveness in non-irradiated SH-SY5Y cells. We first purified the extracellular vesicles released by the SH-SY5Y cells following X-rays, and then determined their total amount, dimensions, membrane protein composition, and cellular uptake. We also examined the effects of these extracellular vesicles on viability, migration, and DNA damage in recipient SH-SY5Y cells. We found that exposure to X-rays increased the release of extracellular vesicles and altered their protein composition. These vesicles were readily uptaken by non-irradiated cells, inducing an increase in viability, migration, and radio-resistance. The same results were obtained in an MYCN-amplified SK-N-BE cell line. Our study demonstrates that vesicles released from irradiated neuroblastoma cells stimulate proliferation and invasiveness that correlate with the epithelial to mesenchymal transition in non-irradiated cells. Moreover, our results suggest that, at least in neuroblastomas, targeting the extracellular vesicles may represent a novel therapeutic approach to counteract the side effects associated with radiotherapy.

1 January 2016 in Journal of Radiation and Cancer Research
Verified
Journal Article
Closed access
PDF file
KMKaushala P Mishra
Kaushala P Mishra
ASAmrita Singh
Amrita Singh
RDRenu Dayal
Renu Dayal
RORudra P Ojha
Rudra P Ojha
Argyreia speciosa (Linn. f.) is a reputed indigenous medicinal plant which possesses various pharmacological properties. The alcoholic root extracts of A. speciosa contains several bioactive compounds including flavonoids (quercetin and kaempferol), coumarins (scopoletin), alkaloid (ergoline), saponins, tannins that have potent free radical scavenging activity and role in cell function modulation in disease conditions. The present review is an attempt to provide an insight of anticancer properties of A. speciosa. It is suggested that extract may have the potential to act as an effective radioprotector to normal cells in cancer radiotherapy.

1 January 2016 in Journal of Radiation and Cancer Research
Verified
Journal Article
Closed access
PDF file
KMKaushala P Mishra
Kaushala P Mishra
ASAmrita Singh
Amrita Singh
RDRenu Dayal
Renu Dayal
RORudra P Ojha
Rudra P Ojha
Argyreia speciosa (Linn. f.) is a reputed indigenous medicinal plant which possesses various pharmacological properties. The alcoholic root extracts of A. speciosa contains several bioactive compounds including flavonoids (quercetin and kaempferol), coumarins (scopoletin), alkaloid (ergoline), saponins, tannins that have potent free radical scavenging activity and role in cell function modulation in disease conditions. The present review is an attempt to provide an insight of anticancer properties of A. speciosa. It is suggested that extract may have the potential to act as an effective radioprotector to normal cells in cancer radiotherapy.